logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table INF-115. Prevalence of antibodies against hepatitis B virus among injecting drug users (%), 1991 to 2007

(see the help page for information about formats etc.)

Page last updated: Wednesday, 01 July 2009